《Genes & Diseases》雜志的最新年發文量為153篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章，以保持其在生化與分子生物學領域的學術影響力。
該刊聚焦于醫學-生化與分子生物學領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為約Time to First Decision: 2.3 weeks; Review Time: 3.7 weeks; Publication Time: 1.6 weeks; 50 Weeks 。
Genes & Diseases 雜志發文統計
文章名稱引用次數
- Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis60
- Immunogenic effects of chemotherapy-induced tumor cell death45
- Epigenetic mechanisms as a new approach in cancer treatment: An updated review39
- DNA methylation in human diseases37
- Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review34
- Emerging roles of lncRNAs in the post-transcriptional regulation in cancer34
- Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicine20
- Regulation and functions of integrin alpha 2 in cell adhesion and disease20
- Resveratrol provides neuroprotection by regulating the JAK2/STAT3/PI3K/AKT/mTOR pathway after stroke in rats17
- Impact of gene mutation in the development of Parkinson's disease11
國家/地區發文量
- CHINA MAINLAND95
- India86
- USA54
- Iran5
- Egypt4
- England4
- Canada2
- Italy2
- Saudi Arabia2
- Thailand2
